Trial intelligence / Profile preview

Mepivacaine for Pain Relief at IUC Insertion

NCT02078063Phase 3Completed

Sponsor
Karolinska Institutet
Start
Nov 2013
Primary completion
Nov 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mepivacaine in procedural pain, sponsored by Karolinska Institutet. Started Nov 2013; status: completed.

02

Drugs

mepivacaine
03

Conditions

procedural pain

Beyond the preview

Go deeper on NCT02078063.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02078063.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call